Trials / Completed
CompletedNCT00755482
Effects of Aquamin F on NSAID Dose Reduction in Osteoarthritis of the Knee
Randomised, Placebo Controlled Trial to Examine the Effect of Aquamin F on NSAID Dose Reduction in Subjects With Osteoarthritis of the Knee.
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Marigot Ltd. · Industry
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The objective of this trial is to evaluate the effect of Aquamin F versus placebo on NSAID (non-steroidal anti-inflammatory drug) dose reduction in subjects with osteoarthritis of the knee. Hypothesis 1: After 12 weeks of treatment, subjects taking Aquamin F will use significantly less NSAID medications for symptoms of osteoarthritis versus placebo alone. Hypothesis 2: No significant differences will be seen for adverse events between the subjects taking Aquamin F or placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aquamin F | |
| DRUG | Placebo (maltodextran) |
Timeline
- Start date
- 2006-01-01
- Completion
- 2006-09-01
- First posted
- 2008-09-19
- Last updated
- 2008-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00755482. Inclusion in this directory is not an endorsement.